Diseases of the Colon & Rectum

, Volume 42, Issue 11, pp 1369–1380 | Cite as

Research in colon and rectal cancer, with an emphasis on surgical progress

  • Alex J. Ky
  • Max W. Sung
  • Jeffrey W. Milsom
Centennial Articles In Colon And Rectal Surgery


Public Health Rectal Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Troidl H, Spitzer WO, Mulder DS,et al. eds. Principles and practice of research: strategies for surgical investigators. New York: Springer, 1991.Google Scholar
  2. 2.
    Popper K. Conjectures and refutations. the growth of scientific knowledge. 4th ed. London: Routledge & Kegan Paul, 1972:129.Google Scholar
  3. 3.
    Stamp J. Quoted by Dunea G. Swallowing the golden ball. BMJ 1983;286:1962–3.Google Scholar
  4. 4.
    Yates F, Mather K. Ronald Aylmer Fisher 1890–1962. Biographical Memoirs of Fellows of the Royal Society 1963;9:91–129.Google Scholar
  5. 5.
    Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948;2:769–82.Google Scholar
  6. 6.
    Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967;201:943–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Mandel JS, Bond JH, Church TR,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365–71.CrossRefPubMedGoogle Scholar
  8. 8.
    Kronborg O, Fenger C, Olsen O, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.CrossRefPubMedGoogle Scholar
  9. 9.
    Hardcastle JD, Chamberlain JO, Robinson MH,et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Banov L. Hippocratic proctology. South Med J 1967;60:667–70.PubMedGoogle Scholar
  11. 11.
    Turell R. Diseases of the colon and rectum. Philadelphia: WB Saunders, 1969.Google Scholar
  12. 12.
    Tuttle JP. A treatise on diseases of the anus, rectum, and pelvic colon. New York: D Appleton, 1907.Google Scholar
  13. 13.
    Overholt BF. Flexible fiberoptic sigmoidoscopy: technique and preliminary results. Cancer 1971;28:123–6.PubMedGoogle Scholar
  14. 14.
    Wolff WI, Shinya H. Colonofiberoscopy. JAMA 1971;217:1509–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Winawer SJ, Zauber AG, Ho MN,et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977–81.CrossRefPubMedGoogle Scholar
  16. 16.
    Cannon W. The movements of the stomach studied by means of the roentgen rays. Am J Physiol 1898;1:359–82.Google Scholar
  17. 17.
    Fischer AW. A new roentgenologic method for examination of the large intestine: a combination of the contrast material enema and insufflation of air [in German]. Klin Wochenschr 1923;2:1595–8.CrossRefGoogle Scholar
  18. 18.
    Welin S, Youker J, Spratt JS Jr. The rates and patterns of growth of 375 tumors of the large intestine and rectum observed serially by double contrast enema study (Malmo Technique). AJR 1963;90:673–87.Google Scholar
  19. 19.
    Ruo L, Guillem JG. Major 20th-century advancements in the management of rectal cancer. Dis Colon Rectum 1999;42:563–78.PubMedGoogle Scholar
  20. 20.
    Royster AP, Fenlon HM, Clarke PD,et al. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc 1997;45:451–5.PubMedGoogle Scholar
  21. 21.
    Lumboldt W, Debatin JF. Virtual endoscopic colonography based on 3D MRI. Abdom Imaging 1998;23:568–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Valk PE, Abella-Columna E, Haseman MK,et al. Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503–11.CrossRefPubMedGoogle Scholar
  23. 23.
    Wolff BG, Bolton J, Baum R,et al. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally human monoclonal antibody: patient management benefit from a Phase III multicenter study. Dis Colon Rectum 1998;41:953–62.CrossRefPubMedGoogle Scholar
  24. 24.
    Scheithauer W, Rosen H, Kornek G, Sebesta C, Depisch D. Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306:752–5.PubMedGoogle Scholar
  25. 25.
    The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896–903.Google Scholar
  26. 26.
    Cunningham D, Pyrhonen S, James RD,et al. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352:1413–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Saltz LB, Locker PK, Pirotta N,et al. Weekly irinotecan (CPT-11), leucovorin (LV), and fluorouracil (FU) is superior to daily x5 LV/FU in patients with previous untreated metastatic colorectal cancer (CRC) [abstract]. Proc Am Soc Clin Oncol 1999;20:898A.Google Scholar
  28. 28.
    DeGramont A, Figer A, Seymour M,et al. A randomized trial of leucovorin and 5-fluorouracil with or without oxaliplatin in advanced colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1998;19:985A.Google Scholar
  29. 29.
    Carmichael J, Popiela T, Radstone D, Falk S,et al. Randomized comparative study of ORZEL (oral uracil/tegafur (UFT) plus leucovorin) versus parenteral 5-flourouracil plus leucovorin in patients with metastatic colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1999;20:1015A.Google Scholar
  30. 30.
    Cox JV, Pzadur R, Thibault A. A phase III trial of XELODA (Capecitabine) in previously untreated advanced/metastatic colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1999;20:1069A.Google Scholar
  31. 31.
    Brunet R, Fonck M, Smith D,et al. Management of metastatic colorectal cancer (MCRC): results of a strategy with first line Tomudex chemotherapy [abstract]. Proc Am Soc Clin Oncol 1999;20:1069A.Google Scholar
  32. 32.
    Huang Y, Waxman S. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate. Clin Cancer Res 1998;4:2503–9.PubMedGoogle Scholar
  33. 33.
    Sung MW, Waxman S. Chemodifferentiation therapy with fluorouracil and phenylbutyrate in advanced colorectal cancer: a phase I trial [abstract]. Proc Am Assoc Cancer Res 1999;40:2245A.Google Scholar
  34. 34.
    Kenemy N, Conti JA, Cohen A.,et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994;12:2288–95.PubMedGoogle Scholar
  35. 35.
    Moertel CG, Fleming TR, Macdonald JS,et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of Stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321–6.PubMedGoogle Scholar
  36. 36.
    O'Connell MJ, Laurie JA, Shepherd L,et al. A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for high-risk colon cancer: a collaborative trial of the North Central Cancer Treatment Group and the National Cancer Institute of Canada Clinical Trials Group. Proc Am Soc Clin Oncol 1996;15:209.Google Scholar
  37. 37.
    Riethmuller G, Schneider-Gadicke E, Schlimok G,et al., and the German Cancer Aid 17-1A Study Group. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;33:1177–83.CrossRefGoogle Scholar
  38. 38.
    Gastroinestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465–72.Google Scholar
  39. 39.
    Krook JE, Moertel CG, Gunderson LL,et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–15.PubMedGoogle Scholar
  40. 40.
    O'Connell MJ, Martenson JA, Weiand HS,et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation after curative surgery. N Engl J Med 1994;331:502–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Chen SH, Chen XH, Wang Y,et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A 1995;92:2577–81.PubMedGoogle Scholar
  42. 42.
    Sung MW, Yeh HC, Mandeli JP,et al. Intratumoral suicide gene therapy in colorectal cancer metastatic to the liver: a phase I trial of recombinant adenoviral vector expressing the Herpes Simplex Virus thymidine kinase followed by intravenous ganciclovir. Proc Am Assoc Cancer Res 1999;40:2103A.Google Scholar
  43. 43.
    Chen SH, Kosai K, Xu B,et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 1996;56:3758–62.PubMedGoogle Scholar
  44. 44.
    Caruso M, Pham-Nguyen K, Kwong YL,et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci U S A 1996;93:11302–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Anderson SC, Johnson DE, Harris MP,et al. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. Clin Cancer Res 1998;4:1649–59.PubMedGoogle Scholar
  46. 46.
    Rutkow IM. Surgery. An Illustrated History. Saint Louis: Mosby-Year Book, 1993.Google Scholar
  47. 47.
    US Department of Health, and Human Services. Closing in on cancer: solving a 5000-year-old mystery. NIH Publication no. 87-2955, 1987.Google Scholar
  48. 48.
    Lockhart-Mummery P. Resection of the rectum for cancer. Lancet 1920;1:20–1.CrossRefGoogle Scholar
  49. 49.
    Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;2:1812–3.Google Scholar
  50. 50.
    Rankin FW. The technique of anterior resection of the rectosigmoid. Surg Gynecol Obstet 1928;46:537–46.Google Scholar
  51. 51.
    Dixon CF. Anterior resection for malignant lesions of the upper part of the rectum and lower part of the sigmoid. Ann Surg 1948;128:425–42.Google Scholar
  52. 52.
    Heald RJ. Towards fewer colostomies—the impact of circular stapling devices on the surgery of rectal cancer in a district hospital. Br J Surg 1980;60:198–200.Google Scholar
  53. 53.
    Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma—experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995;81(Suppl):60–4.PubMedGoogle Scholar
  54. 54.
    Reybard TF. Memoire sur une Tumeur Cancereuse affectant l's iliaque du colon; ablation de la tumeur et de l'intestin; Reunion directe et immediate de deux bouts de cet organe; guerison. Bull Acad Royale de Med 1943–44;9:1031.Google Scholar
  55. 55.
    Paul FT. Colectomy. BMJ 1895;1:1136.Google Scholar
  56. 56.
    von Mikulicz J. Chirurgische erjahrun uber das Darmcarcinom. Arch Klin Chir Berl 1903;69:28.Google Scholar
  57. 57.
    Bloch OT. Om extra-abdominal behandlung af cancer intestinalis (rectum derfra undtaget) med en frem stilling af do for denne sugdom foretague operationer og deres resultater. Nord Med Arh 1982;24:1.Google Scholar
  58. 58.
    Black WA, Waugh JM. The intramural extension of carcinoma of the descending colon, sigmoid, and rectosigmoid: a pathologic study. Surg Gynecol Obstet 1948;87:457–64.Google Scholar
  59. 59.
    Grinnell RS. Results of ligation of inferior mesenteric artery at the aorta in resections of carcinoma of the descending and sigmoid colon and rectum. Surg Gynecol Obstet 1965;120:1031–6.PubMedGoogle Scholar
  60. 60.
    Grinnell RS, Hiatt RB. Ligation of the inferior mesenteric artery at the aorta in resections for carcinoma of the sigmoid and rectum. Surg Gynecol Obstet 1952;94:526–9.PubMedGoogle Scholar
  61. 61.
    Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420–7.PubMedGoogle Scholar
  62. 62.
    Parc YR, Radice Em, Dozois RR. Surgery for ulcerative colitis: Historical perspective. Dis Colon Rectum 1999;42:299–306.CrossRefPubMedGoogle Scholar
  63. 63.
    Cosimelli M, Mannella E, Giannarelli D,et al. Nervesparing surgery in 302 resectable rectosigmoid cancer patients: genitourinary morbidity and 10-year survival. Dis Colon Rectum 1994;37(Suppl):S42–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Havenga K, Enker WE, McDermott K,et al. Male and female sexual function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996;182:495–502.PubMedGoogle Scholar
  65. 65.
    Milsom JW, Bohm B, Hammerhofer KA,et al. A prospective randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg 1998;187:46–54.CrossRefPubMedGoogle Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 1999

Authors and Affiliations

  • Alex J. Ky
    • 1
  • Max W. Sung
    • 2
  • Jeffrey W. Milsom
    • 1
  1. 1.From the Division of Colorectal SurgeryMount Sinai School of MedicineNew York
  2. 2.Department of MedicineMount Sinai School of MedicineNew York

Personalised recommendations